Baylon, Marcializa R.
HRN: 00-96-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
CEFUROXIME 1.5GM (VIAL)
02/18/2023
02/19/2023
IV
1.5gm
Q8
S/P TAHBSO
Waiting Final Action
02/19/2023
CEFUROXIME 500MG (TAB)
02/19/2023
02/26/2023
PO
500mg
BID
S/P TAHBSO
Waiting Final Action